Oral budesonide for induction of remission in ulcerative colitis

Complicated diverticulitis mimicking colonic carcinoma: combined approach with endoscopy and budesonide

“…It has an high affinity for the glucocorticoid receptor, and combines an excellent solubility with a strong anti-inflammatory activity. Budesonide exerts its role through a significant downregulation of the inflammation pathways, downregulating several proinflammatory cytokines as tumour necrosis factor-α, IL-1 and 6 (IL-6), and nuclear factor kappa-B 13 14. Budesonide has also lower systemic adverse events when compared with systemic steroids, and the most common of them are Cushingoid face and hypokalemia (due to effects on the endocrine organs) 15…”

Complicated diverticulitis mimicking colonic carcinoma: combined approach with endoscopy and budesonide

“…It has an high affinity for the glucocorticoid receptor, and combines an excellent solubility with a strong anti-inflammatory activity. Budesonide exerts its role through a significant downregulation of the inflammation pathways, downregulating several proinflammatory cytokines as tumour necrosis factor-α, IL-1 and 6 (IL-6), and nuclear factor kappa-B 13 14. Budesonide has also lower systemic adverse events when compared with systemic steroids, and the most common of them are Cushingoid face and hypokalemia (due to effects on the endocrine organs) 15…”

Association of Upper GI Bleed in Patients with Budesonide and SSRI Therapy in Chrons Disease: A Comparative Clinical Study

“…However, significant adverse effects have led to the development of second generation GCs (budesonide, Beclomethasone dipropionate. (51,52,53) Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed to treat depression and again depression requires months or even years of continuous pharmacotherapy.…”

Management of Paediatric Ulcerative Colitis, Part 1

“…A Cochrane systematic review of older selective release budesonide in adults showed that it was less likely to induce remission than mesalamine (relative risk [RR] 0.72, 95% confidence interval [CI] 0.57-0.91) with no benefit over placebo (RR 1.41, 95% CI 0.59-3.39) (114). Budesonide-MMX is a novel oral formulation designed to extend release of the drug to the colon.…”

Complicated diverticulitis mimicking colonic carcinoma: combined approach with endoscopy and budesonide

“…It has an high affinity for the glucocorticoid receptor, and combines an excellent solubility with a strong anti-inflammatory activity. Budesonide exerts its role through a significant downregulation of the inflammation pathways, downregulating several proinflammatory cytokines as tumour necrosis factor-α, IL-1 and 6 (IL-6), and nuclear factor kappa-B 13 14. Budesonide has also lower systemic adverse events when compared with systemic steroids, and the most common of them are Cushingoid face and hypokalemia (due to effects on the endocrine organs) 15…”

Association of Upper GI Bleed in Patients with Budesonide and SSRI Therapy in Chrons Disease: A Comparative Clinical Study

“…However, significant adverse effects have led to the development of second generation GCs (budesonide, Beclomethasone dipropionate. (51,52,53) Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed to treat depression and again depression requires months or even years of continuous pharmacotherapy.…”

Management of Paediatric Ulcerative Colitis, Part 1

“…A Cochrane systematic review of older selective release budesonide in adults showed that it was less likely to induce remission than mesalamine (relative risk [RR] 0.72, 95% confidence interval [CI] 0.57-0.91) with no benefit over placebo (RR 1.41, 95% CI 0.59-3.39) (114). Budesonide-MMX is a novel oral formulation designed to extend release of the drug to the colon.…”

Complicated diverticulitis mimicking colonic carcinoma: combined approach with endoscopy and budesonide

“…It has an high affinity for the glucocorticoid receptor, and combines an excellent solubility with a strong anti-inflammatory activity. Budesonide exerts its role through a significant downregulation of the inflammation pathways, downregulating several proinflammatory cytokines as tumour necrosis factor-α, IL-1 and 6 (IL-6), and nuclear factor kappa-B 13 14. Budesonide has also lower systemic adverse events when compared with systemic steroids, and the most common of them are Cushingoid face and hypokalemia (due to effects on the endocrine organs) 15…”

Association of Upper GI Bleed in Patients with Budesonide and SSRI Therapy in Chrons Disease: A Comparative Clinical Study

“…However, significant adverse effects have led to the development of second generation GCs (budesonide, Beclomethasone dipropionate. (51,52,53) Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed to treat depression and again depression requires months or even years of continuous pharmacotherapy.…”

Management of Paediatric Ulcerative Colitis, Part 1

“…A Cochrane systematic review of older selective release budesonide in adults showed that it was less likely to induce remission than mesalamine (relative risk [RR] 0.72, 95% confidence interval [CI] 0.57-0.91) with no benefit over placebo (RR 1.41, 95% CI 0.59-3.39) (114). Budesonide-MMX is a novel oral formulation designed to extend release of the drug to the colon.…”